Use of Intraoperative Contrast-Enhanced Ultrasound to Evaluate Femoral Head Perfusion in Infants With Developmental Hip Dysplasia After Surgical Reduction

Trial Profile

Use of Intraoperative Contrast-Enhanced Ultrasound to Evaluate Femoral Head Perfusion in Infants With Developmental Hip Dysplasia After Surgical Reduction

Active, no longer recruiting
Phase of Trial: Phase 0

Latest Information Update: 06 Jul 2017

At a glance

  • Drugs Sulfur hexafluoride (Primary)
  • Indications Postoperative complications
  • Focus Diagnostic use
  • Most Recent Events

    • 30 Jun 2017 Status changed from recruiting to active, no longer recruiting.
    • 01 Jun 2017 Planned End Date changed from 10 Apr 2020 to 1 Apr 2020.
    • 01 Jun 2017 Planned primary completion date changed from 10 Apr 2019 to 1 Apr 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top